Literature DB >> 9712543

Sclerosteosis: report of a case in a black African man.

P Tacconi1, P Ferrigno, L Cocco, A Cannas, G Tamburini, P Bergonzi, M Giagheddu.   

Abstract

Sclerosteosis is a rare genetic disorder of bone modelling, similar to, but distinct from, van Buchem disease; it has been described almost exclusively in Afrikaners of South Africa, a white population of Dutch ancestry. Isolated cases have been reported in a girl in Japan, a boy in Spain, and in multiracial families in Brazil and USA. Here we report a case of sclerosteosis in a black man born in Senegal. He presented with the full features of the disease: tall stature; syndactyly: nail dysplasia; massive sclerosis of the long tubular bones, the ribs, the pelvis and the skull; multiple cranial nerve involvement: optic atrophy, facial palsy and trigeminal neuralgia. Radiologic examination, visual and brainstem auditory evoked potentials, computerized tomography and magnetic resonance imaging of the skull were performed. This seems to be the first case of the disease in a black African individual, with no known relationship with Dutch ancestry.

Entities:  

Mesh:

Year:  1998        PMID: 9712543     DOI: 10.1111/j.1399-0004.1998.tb02603.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.

Authors:  W Balemans; J Van Den Ende; A Freire Paes-Alves; F G Dikkers; P J Willems; F Vanhoenacker; N de Almeida-Melo; C F Alves; C A Stratakis; S C Hill; W Van Hul
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

Review 2.  Sclerostin: therapeutic horizons based upon its actions.

Authors:  Aline G Costa; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

3.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

4.  Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.

Authors:  W Balemans; N Patel; M Ebeling; E Van Hul; W Wuyts; C Lacza; M Dioszegi; F G Dikkers; P Hildering; P J Willems; J B G M Verheij; K Lindpaintner; B Vickery; D Foernzler; W Van Hul
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

5.  High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men.

Authors:  Laura M Yerges; Lambertus Klei; Jane A Cauley; Kathryn Roeder; Candace M Kammerer; Susan P Moffett; Kristine E Ensrud; Cara S Nestlerode; Lynn M Marshall; Andrew R Hoffman; Cora Lewis; Thomas F Lang; Elizabeth Barrett-Connor; Robert E Ferrell; Eric S Orwoll; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2009-12       Impact factor: 6.741

6.  A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin.

Authors:  Aishah A Ekhzaimy; Ebtihal Y Alyusuf; Meshael Alswailem; Ali S Alzahrani
Journal:  Medicina (Kaunas)       Date:  2022-01-28       Impact factor: 2.430

Review 7.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

8.  Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist.

Authors:  Rutger L van Bezooijen; Bernard A J Roelen; Annemieke Visser; Lianne van der Wee-Pals; Edwin de Wilt; Marcel Karperien; Herman Hamersma; Socrates E Papapoulos; Peter ten Dijke; Clemens W G M Löwik
Journal:  J Exp Med       Date:  2004-03-15       Impact factor: 14.307

9.  Management of trigeminal neuralgia in sclerosteosis.

Authors:  Emerson Magno de Andrade; André Beer-Furlan; Kleber Paiva Duarte; Erich Talamoni Fonoff; Manoel Jacobsen Teixeira
Journal:  Surg Neurol Int       Date:  2013-11-20

Review 10.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.